Teachers’ Pension to establish ESG management committee Move is part of efforts by Korean pension fund to integrate ESG into investment decisions
Translated by Ryu Ho-joung 공개 2021-10-28 08:07:12
이 기사는 2021년 10월 28일 08:05 thebell 에 표출된 기사입니다.
Teachers’ Pension is set to create a committee to oversee environment, social and governance (ESG) matters in its latest push to integrate ESG factors into the fund’s management.The Korean pension scheme’s board of directors recently approved the establishment of the ESG management committee, according to industry sources on Tuesday.
The newly created committee will be responsible for matters related to the pension scheme’s ESG management – including setting up ESG strategy and directions, developing ESG initiatives and monitoring ESG risks.
The committee will consist of at least seven but no more than nine members. External directors should comprise half of the total. Approvals require attendance of a majority of the committee’s all members and support from a majority of the members present.
The move is part of efforts by the pension fund to incorporate ESG into its operations and investment process. Teachers’ Pension earlier this year hired a consulting firm to review its management strategy including an ESG roadmap.
Teachers’ Pension included ESG factors in the criteria when selecting external managers for its domestic equities portfolio in May. It also required managers to disclose their ESG policies and performance in a tender process to award private equity mandates this summer.
According to its ESG roadmap, Teachers’ Pension will build concrete ESG initiatives in the mid to long term and integrate ESG factors into its overall governance by 2023. It also plans to receive an ESG rating by 2025. (Reporting by Hee-yeon Han)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- 코인원, 이용규 CPO 영입…신규 서비스 출시 속도
- [코스닥 코스메틱 리뉴얼]마스크팩 잘나가던 지피클럽, 색조화장 '코디 인수'
- [K-배터리 밸류업 리포트]'오너 경영체제' 원준, 승계작업 '언제쯤'
- [thebell note]제약바이오는 다이어트 중
- [바이오텍 유증·메자닌 승부수]브릿지바이오, 유무상증자에 '대표 지분 블록딜' 왜?
- [제일약품의 온코닉테라퓨틱스 첫 '신약']성장성·사업성 갖춘 IPO 기대주 '밸류업' 이유 더 있다
- [코스닥 리빌딩 리포트]'조달 지연' 비투엔, 불성실공시법인 지정 가능성은
- [Board Index/네이버]사외이사 정보제공 '정조준'…교육도 대폭 늘려
- "35년 영업맨, 상장 후 글로벌 시장 노린다"
- [아시아나 화물사업부 M&A]LOC 낸 에어인천·이스타, LOI 낸 에어프레미아